Skip to main content
. 2017 Feb 17;177(3):404–413. doi: 10.1111/bjh.14549

Figure 1.

Figure 1

Kaplan–Meier PFS Curves for (A) <70 years of Age Subgroup and (B) ≥70 years of Age Subgroup. CI, confidence interval; HR, hazard ratio; KRd, carfilzomib‐lenalidomide‐dexamethasone; mo, months; PFS, progression‐free survival; Rd, lenalidomide‐dexamethasone